Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing–remitting multiple sclerosis subjects

Authors:

Abstract
No abstract available
Funding Information
  • ApoPharma, Inc. (SML)
  • National Multiple Sclerosis Society (New York, USA) (SML)
  • National Institute of Aging (AG23946)

This publication has 24 references indexed in Scilit: